Brain Tumors in Adults

We take on the most difficult to treat brain tumors, including glioblastomas, gliomas, astrocytomas, meningiomas, and metastatic brain tumors. We’re nationally known for providing innovative precision molecular diagnoses for brain tumors, and for our expertise in neurosurgery, neuro-oncology, and Gamma Knife®, a precisely targeted radiation treatment for complex brain tumors. We believe that, in some cases, the standard of care may be outdated and might not be the best treatment for you. That’s why we base your care plan on the tumor’s precise molecular makeup, delivering truly individualized care with compassion. We also design cutting-edge clinical trials to find promising new treatments.

Clinical Trials and Research Studies

Phase 2

A single arm open-label multicenter phase II study of 177Lu-DOTATATE radionuclide in adults with progressive or high-risk meningioma

Learn More

Phase 2

ACNS1721: A Phase 2 Study of Veliparib (ABT-888 IND # 139199) and Local Irradiation Followed by Maintenance Veliparib and Temozolomide in Patients with Newly Diagnosed High-Grade Glioma (HGG) without H3 K27M or BRAFV600E Mutations

Learn More

Phase 2

APEC1621J: NCI-COG PEDIATRIC MATCH (MOLECULAR ANALYSIS FOR THERAPY CHOICE)-PHASE 2 SUBPROTOCOL OF BVD-523FB (ULIXERTINIB) IN PATIENTS WITH TUMORS HARBORING ACTIVATING MAPK PATHWAY MUTATIONS

Learn More

Phase 2

APEC1621C: NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Phase 2 Subprotocol of Tazemetostat in Patients with Tumors Harboring Alterations in EZH2 or Members of the SWI/SNF Complex

Learn More